Cargando…
Frailty and Inflammatory Bowel Disease: A Scoping Review of Current Evidence
Frailty is increasingly recognized as an important concept in patients with Inflammatory Bowel Disease (IBD). The aim of this scoping review is to summarize the current literature on frailty in IBD. We will discuss the definition of frailty, frailty assessment methods, the prevalence of frailty, ris...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860672/ https://www.ncbi.nlm.nih.gov/pubmed/36675461 http://dx.doi.org/10.3390/jcm12020533 |
_version_ | 1784874643673317376 |
---|---|
author | Fons, Anne Kalisvaart, Kees Maljaars, Jeroen |
author_facet | Fons, Anne Kalisvaart, Kees Maljaars, Jeroen |
author_sort | Fons, Anne |
collection | PubMed |
description | Frailty is increasingly recognized as an important concept in patients with Inflammatory Bowel Disease (IBD). The aim of this scoping review is to summarize the current literature on frailty in IBD. We will discuss the definition of frailty, frailty assessment methods, the prevalence of frailty, risk factors for frailty and the prognostic value of frailty in IBD. A scoping literature search was performed using the PubMed database. Frailty prevalence varied from 6% to 53.9%, depending on the population and frailty assessment method. Frailty was associated with a range of adverse outcomes, including an increased risk for all-cause hospitalization and readmission, mortality in non-surgical setting, IBD-related hospitalization and readmission. Therefore, frailty assessment should become integrated as part of routine clinical care for older patients with IBD. |
format | Online Article Text |
id | pubmed-9860672 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98606722023-01-22 Frailty and Inflammatory Bowel Disease: A Scoping Review of Current Evidence Fons, Anne Kalisvaart, Kees Maljaars, Jeroen J Clin Med Review Frailty is increasingly recognized as an important concept in patients with Inflammatory Bowel Disease (IBD). The aim of this scoping review is to summarize the current literature on frailty in IBD. We will discuss the definition of frailty, frailty assessment methods, the prevalence of frailty, risk factors for frailty and the prognostic value of frailty in IBD. A scoping literature search was performed using the PubMed database. Frailty prevalence varied from 6% to 53.9%, depending on the population and frailty assessment method. Frailty was associated with a range of adverse outcomes, including an increased risk for all-cause hospitalization and readmission, mortality in non-surgical setting, IBD-related hospitalization and readmission. Therefore, frailty assessment should become integrated as part of routine clinical care for older patients with IBD. MDPI 2023-01-09 /pmc/articles/PMC9860672/ /pubmed/36675461 http://dx.doi.org/10.3390/jcm12020533 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Fons, Anne Kalisvaart, Kees Maljaars, Jeroen Frailty and Inflammatory Bowel Disease: A Scoping Review of Current Evidence |
title | Frailty and Inflammatory Bowel Disease: A Scoping Review of Current Evidence |
title_full | Frailty and Inflammatory Bowel Disease: A Scoping Review of Current Evidence |
title_fullStr | Frailty and Inflammatory Bowel Disease: A Scoping Review of Current Evidence |
title_full_unstemmed | Frailty and Inflammatory Bowel Disease: A Scoping Review of Current Evidence |
title_short | Frailty and Inflammatory Bowel Disease: A Scoping Review of Current Evidence |
title_sort | frailty and inflammatory bowel disease: a scoping review of current evidence |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860672/ https://www.ncbi.nlm.nih.gov/pubmed/36675461 http://dx.doi.org/10.3390/jcm12020533 |
work_keys_str_mv | AT fonsanne frailtyandinflammatoryboweldiseaseascopingreviewofcurrentevidence AT kalisvaartkees frailtyandinflammatoryboweldiseaseascopingreviewofcurrentevidence AT maljaarsjeroen frailtyandinflammatoryboweldiseaseascopingreviewofcurrentevidence |